249 related articles for article (PubMed ID: 26696395)
1. HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).
Jensen SS; Fomsgaard A; Borggren M; Tingstedt JL; Gerstoft J; Kronborg G; Rasmussen LD; Pedersen C; Karlsson I
PLoS One; 2015; 10(12):e0145249. PubMed ID: 26696395
[TBL] [Abstract][Full Text] [Related]
2. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection.
Konstantinus IN; Gamieldien H; Mkhize NN; Kriek JM; Passmore JA
J Immunol Methods; 2016 Jul; 434():46-52. PubMed ID: 27094485
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells.
Fisher L; Zinter M; Stanfield-Oakley S; Carpp LN; Edwards RW; Denny T; Moodie Z; Laher F; Bekker LG; McElrath MJ; Gilbert PB; Corey L; Tomaras G; Pollara J; Ferrari G
Front Immunol; 2019; 10():2741. PubMed ID: 31827470
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ
J Infect Dis; 2015 Feb; 211(4):529-38. PubMed ID: 25170105
[TBL] [Abstract][Full Text] [Related]
5. HIV-specific ADCC improves after antiretroviral therapy and correlates with normalization of the NK cell phenotype.
Jensen SS; Hartling HJ; Tingstedt JL; Larsen TK; Nielsen SD; Pedersen C; Fomsgaard A; Karlsson I
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):103-11. PubMed ID: 25394194
[TBL] [Abstract][Full Text] [Related]
6. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
Ahmad A; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
[TBL] [Abstract][Full Text] [Related]
7. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell education does not affect the magnitude of granzyme B delivery to target cells by antibody-dependent cellular cytotoxicity.
Isitman G; Lisovsky I; Tremblay-McLean A; Parsons MS; Shoukry NH; Wainberg MA; Bruneau J; Bernard NF
AIDS; 2015 Jul; 29(12):1433-43. PubMed ID: 26244383
[TBL] [Abstract][Full Text] [Related]
9. Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.
Jia M; Li D; He X; Zhao Y; Peng H; Ma P; Hong K; Liang H; Shao Y
Clin Exp Immunol; 2013 Jan; 171(1):107-16. PubMed ID: 23199330
[TBL] [Abstract][Full Text] [Related]
10. The Early Antibody-Dependent Cell-Mediated Cytotoxicity Response Is Associated With Lower Viral Set Point in Individuals With Primary HIV Infection.
Chen X; Lin M; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Dong T; Shang H; Jiang Y
Front Immunol; 2018; 9():2322. PubMed ID: 30356637
[TBL] [Abstract][Full Text] [Related]
11. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
[TBL] [Abstract][Full Text] [Related]
12. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
13. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
[TBL] [Abstract][Full Text] [Related]
14. FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32).
Bhatnagar N; Ahmad F; Hong HS; Eberhard J; Lu IN; Ballmaier M; Schmidt RE; Jacobs R; Meyer-Olson D
Eur J Immunol; 2014 Nov; 44(11):3368-79. PubMed ID: 25100508
[TBL] [Abstract][Full Text] [Related]
15. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.
Pollara J; Hart L; Brewer F; Pickeral J; Packard BZ; Hoxie JA; Komoriya A; Ochsenbauer C; Kappes JC; Roederer M; Huang Y; Weinhold KJ; Tomaras GD; Haynes BF; Montefiori DC; Ferrari G
Cytometry A; 2011 Aug; 79(8):603-12. PubMed ID: 21735545
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection.
Liu Q; Sun Y; Rihn S; Nolting A; Tsoukas PN; Jost S; Cohen K; Walker B; Alter G
J Virol; 2009 Sep; 83(17):8705-12. PubMed ID: 19553339
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
Loubeau M; Ahmad A; Toma E; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
[TBL] [Abstract][Full Text] [Related]
18. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
Tomescu C; Tebas P; Montaner LJ
AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals.
Ahmad A; Morisset R; Thomas R; Menezes J
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):428-37. PubMed ID: 7908983
[TBL] [Abstract][Full Text] [Related]
20. Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.
Lichtfuss GF; Cheng WJ; Farsakoglu Y; Paukovics G; Rajasuriar R; Velayudham P; Kramski M; Hearps AC; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
J Immunol; 2012 Aug; 189(3):1491-9. PubMed ID: 22745371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
